Saturday, 5 September 2026European Markets

WERELDHAVE BELGIUM And VASTNED BELGIUM Have A High Dividend Yield And Return On Equity In The REIT—Retail Industry.

Loading stream...

(VIANEWS) - WERELDHAVE BELGIUM (WEHB.BR) is among this list of stock assets with the highest dividend rate and return on equity on the REIT—Retail industry.

Financial Asset Price Forward Dividend Yield Return on Equity
WERELDHAVE BELGIUM (WEHB.BR) €49.10 8.57% 8.05%
VASTNED BELGIUM (VASTB.BR) €28.20 7.68% 5.92%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. WERELDHAVE BELGIUM (WEHB.BR)

8.57% Forward Dividend Yield and 8.05% Return On Equity

Wereldhave Belgium is a public regulated real estate company with a focus on commercial property in Belgium. Wereldhave Belgium targets its new investments on shopping centres. The value of the real estate portfolio, including project developments, amounted to € 921.2 mln on 31 December 2020. On 31 December 2020 the existing operational retail portfolio amounted to € 817.8 mln (around 90% of the total portfolio) and it includes shopping centres in Liège, Nivelles, Tournai, Genk and Kortrijk and retail parks in Brugge, Ghent, Turnhout, Waterloo and Tournai. In addition, the portfolio of real estate investments includes offices in Vilvoorde and Antwerp. As of 31 December 2020 the development portfolio of € 12.6 mln contained land holdings and realised investments that relate to the refurbishment and/or expansion of shopping centres in Waterloo and Liège.

Earnings Per Share

As for profitability, WERELDHAVE BELGIUM has a trailing twelve months EPS of €6.25.

PE Ratio

WERELDHAVE BELGIUM has a trailing twelve months price to earnings ratio of 7.86. Meaning, the purchaser of the share is investing €7.86 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.05%.

Moving Average

WERELDHAVE BELGIUM's worth is above its 50-day moving average of €48.06 and below its 200-day moving average of €50.71.

More news about WERELDHAVE BELGIUM.

2. VASTNED BELGIUM (VASTB.BR)

7.68% Forward Dividend Yield and 5.92% Return On Equity

Vastned Belgium is a public regulated real estate company (RREC), the shares of which are listed on Euronext Brussels (VASTB). Vastned Belgium invests exclusively in Belgian commercial real estate, more specifically in multi-functional retail properties located in the popular shopping cities of Antwerp, Brussels, Ghent and Bruges. The real estate portfolio also comprises high-end retail parks and retail warehouses. A smaller part of the portfolio is invested in hospitality and residential units.

Earnings Per Share

As for profitability, VASTNED BELGIUM has a trailing twelve months EPS of €2.79.

PE Ratio

VASTNED BELGIUM has a trailing twelve months price to earnings ratio of 10.11. Meaning, the purchaser of the share is investing €10.11 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.92%.

Moving Average

VASTNED BELGIUM's value is below its 50-day moving average of €28.83 and below its 200-day moving average of €29.69.

More news about VASTNED BELGIUM.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com